Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

Boehm, Thomas, Folkman, Judah, Browder, Timothy, O'Reilly, Michael S.·1997·Nature
DOI 10.1038/37126

Cited by (1,002)

Items 401–500 of 1,002

  1. VCC-1, a novel chemokine, promotes tumor growth
    Edward J. Weinstein, Richard J. Head, David W. Griggs, Duo Sun, Robert J. Evans, Michelle L. Swearingen, Marisa M. Westlin, Richard A. Mazzarella · 2006 · Biochemical and Biophysical Research Communications
  2. Endothelial Cell Surface ATP Synthase-Triggered Caspase-Apoptotic Pathway Is Essential for K1-5-Induced Antiangiogenesis
    Niina Veitonmäki, Renhai Cao, Lin-Hua Wu, Tammy L. Moser, Bo Li, Salvatore Vincent Pizzo, Boris Zhivotovsky, Yihai Cao · 2004 · Cancer Research
  3. Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes
    Süleyman Ergün, Nerbil Kilic, Jan‐Henner Wurmbach, Alireza Ebrahimnejad, Malkanthi Fernando, S. Sevinc, Ergin Kilic, Fariba Chalajour, Walter Fiedler, Heidrun Lauke et al. · 2001 · Angiogenesis
  4. Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties.
    Mohanraj Dhanabal, William J. LaRochelle, Michael Jeffers, John L. Herrmann, Luca Rastelli, William F. McDonald, Rajeev A. Chillakuru, Meijia Yang, Ferenc L. Boldog, Muralidhara Padigaru et al. · 2002 · PubMed
  5. Antiangiogenic effects of melatonin in endothelial cell cultures
    Virginia Alvarez Garcia, Alicia González, Carolina Alonso‐González, Carlos Martínez‐Campa, Samuel Cos · 2013 · Microvascular Research
  6. Gene delivery nanoparticles to modulate angiogenesis
    Jayoung Kim, Adam C. Mirando, Aleksander S. Popel, Jordan J. Green · 2016 · Advanced Drug Delivery Reviews
  7. Inhibition of Human Umbilical Vein Endothelial Cell Proliferation by the CXC Chemokine, Platelet Factor 4 (PF4), Is Associated With Impaired Downregulation of p21Cip1/WAF1
    Grazia Gentilini, Nancy E. Kirschbaum, James A. Augustine, Richard H. Aster, Gian Paolo Visentin · 1999 · Blood
  8. ?-Catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours
    Kim Wright, Peter J. Wilson, Sarah J. Morland, Ian Campbell, Michael D. Walsh, Terry Hurst, Bruce G. Ward, Margaret C. Cummings, Georgia Chenevix‐Trench · 1999 · International Journal of Cancer
  9. Unraveling the mysteries of endostatin
    Yan Fu, Huadong Tang, Yujie Huang, Nan Song, Yongzhang Luo · 2009 · IUBMB Life
  10. Angiogenesis: A Target for Cancer Therapy
    Giampaolo Tortora, Davide Melisi, Fortunato Ciardiello · 2004 · Current Pharmaceutical Design
  11. Application of acoustic droplet vaporization in ultrasound therapy
    Yufeng Zhou · 2015 · Journal of Therapeutic Ultrasound
  12. Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: The St. Jude Children's Research Hospital experience
    Alberto S. Pappo, Bhaskar N. Rao, Jesse J. Jenkins, Thomas E. Merchant, Catherine A. Poquette, Alvida M. Cain, Charles B. Pratt · 1999 · Medical and Pediatric Oncology
  13. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions
    Daniela Massi, Alessandro Franchi, Iacopo Sardi, Lucia Magnelli, Milena Paglierani, Lorenzo Borgognoni, Umberto Maria Reali, Marco Santucci · 2001 · The Journal of Pathology
  14. RETRACTED: <i>Bifidobacteria</i> Expressing Tumstatin Protein for Antitumor Therapy in Tumor-Bearing Mice
    Wei, C., Xun, A. Y., Wei, X. X., Yao, J., Wang, J. Y., Shi, R. Y., Yang, G. H., Li, Y. X., Xu, Z. L., Lai, M. G. et al. · 2016 · Technology in Cancer Research &amp; Treatment · Retracted
  15. Milestones in tumor vascularization and its therapeutic targeting
    Michele De Palma, Douglas Hanahan · 2024 · Nature Cancer
  16. Novel 2,3-Dihydro-1,4-Benzoxazines as Potent and Orally Bioavailable Inhibitors of Tumor-Driven Angiogenesis
    Daniel S. La, Julie Belzile, JAMES V. BREADY, Angela Coxon, Thomas M. DeMelfi, Nicholas Doerr, Juan Estrada, Julie Flynn, Shaun Flynn, Russell F. Graceffa et al. · 2008 · Journal of Medicinal Chemistry
  17. Hypercholesterolemia Impairs the Myocardial Angiogenic Response in a Swine Model of Chronic Ischemia: Role of Endostatin and Oxidative Stress
    Munir Boodhwani, Yasunari Nakai, Shigetoshi Mieno, Pierre Voisine, Cesario F. Bianchi, Eugênio Gonçalves de Araújo, Jun Feng, Keith Michael, Jian Li, Frank William Sellke · 2006 · The Annals of Thoracic Surgery
  18. Surrogate markers in antiangiogenesis clinical trials
    Darren W. Davis, David James McConkey, James L. Abbruzzese, Roy S. Herbst · 2003 · British Journal of Cancer
  19. Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies
    Renaud Grépin, Gilles Pagès · 2010 · Journal of Oncology
  20. Design of a Partial Peptide Mimetic of Anginex with Antiangiogenic and Anticancer Activity
    Kevin H. Mayo, Ruud P.M. Dings, Carolee Flader, Irina V. Nesmelova, Balasz Hargittai, Daisy W.J. van der Schaft, Loes I. van Eijk, Dinesha Walek, Judy Haseman, Thomas R. Hoye et al. · 2003 · Journal of Biological Chemistry
  21. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy
    Jiřina Bártková, Ewa Rajpert‐De Meyts, N. E. Skakkeb�k, Jiří Bártek · 1999 · The Journal of Pathology
  22. Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma
    Rundong Zhang, Lin Hai Tian, Chen Lj, Fei Xiao, J-M Hou, Xia Zhao, G Li, B Yao, Y-J Wen, Jianan Li et al. · 2006 · Gene Therapy
  23. Measuring tumour vascular response to antivascular and antiangiogenic drugs
    Gillian M. Tozer · 2003 · British Journal of Radiology
  24. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
    Xiaojun Huang, Michael K.K. Wong, Huiming Yi, Simon C. Watkins, Alexander Laird, Stanley F. Wolf, Elieser Gorelik · 2002 · PubMed
  25. The Collagen Type XVIII Endostatin Domain Is Co-localized with Perlecan in Basement Membranes in Vivo
    Nicolai Miosge, Timo Simniok, Patricia Sprysch, Rainer Herken · 2003 · Journal of Histochemistry & Cytochemistry
  26. Adeno-Associated Virus 2-Mediated Antiangiogenic Cancer Gene Therapy
    Selvarangan Ponnazhagan, Gandham Mahendra, Sanjay Kumar, Denise R. Shaw, Cecil R. Stockard, William E. Grizzle, Sreelatha Meleth · 2004 · Cancer Research
  27. Dynamics of extracellular matrix in ovarian follicles and corpora lutea of mice
    Helen F. Irving‐Rodgers, Katja Hummitzsch, Lydia S. Murdiyarso, Wendy M. Bonner, Yoshikazu Sado, Yoshifumi Ninomiya, John Couchman, Lydia M. Sorokin, Raymond Joseph Rodgers · 2009 · Cell and Tissue Research
  28. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Lucia Morbidelli, Sandra Donnini, Francesco Chillemi, Antonio Giachetti, Marina Ziche · 2003 · PubMed
  29. Endostatin Exhibits a Direct Antitumor Effect in Addition to Its Antiangiogenic Activity in Colon Cancer Cells
    Fatima Dkhissi, Lu H, Claudine Soria, Paule Opolon, Frank Griscelli, Hanfeng Liu, Patricia Khattar, Zohar Mishal, Michel Perricaudet, Hong Li · 2003 · Human Gene Therapy
  30. The assessment of ovarian tumor angiogenesis: what does three‐dimensional power Doppler add?
    Asım Kurjak, Sanja Plavsic Kupesic, Branko Breyer, Vladimir Šparac, S. Jukic · 1998 · Ultrasound in Obstetrics and Gynecology
  31. Tissue-specific gene therapy directed to tumor angiogenesis
    Nira Varda‐Bloom, Aviv Shaish, Ayelet Gonen, Keren Levanon, S Greenbereger, S Ferber, Hana Levkovitz, D Castel, Iris Goldberg, Arnon B. Afek et al. · 2001 · Gene Therapy
  32. Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12.
    Michael Stanley Gee, Cameron J. Koch, Sydney M. Evans, W. Timothy Jenkins, Charles H. Pletcher, Jonni S. Moore, Holly K. Koblish, Jungeun Jasmine Lee, Edith M. Lord, Giorgio Trinchieri et al. · 1999 · PubMed
  33. Therapeutic potential of interfering with apelin signalling
    Sonia‐Caroline Sorli, Loïc Van Den Berghe, Bernard Masri, Bernard Knibiehler, Yves Audigier · 2006 · Drug Discovery Today
  34. Microbubble Expansion in a Flexible Tube
    Ye Tao, Joseph L. Bull · 2006 · Journal of Biomechanical Engineering
  35. Heparan sulfate in angiogenesis: a target for therapy
    Xander M.R. van Wijk, Toin H. Van Kuppevelt · 2013 · Angiogenesis
  36. Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy
    Joshua Z. Press, Jennifer A. Kenyon, Hui Xue, Melinda A. Miller, Alessandro De Luca, Dianne M. Miller, David D. Huntsman, C. Blake Gilks, Jessica Nell McAlpine, Yuzhuo Z. Wang · 2008 · Gynecologic Oncology
  37. Autophagy, a double-edged sword in anti-angiogenesis therapy
    Jiatao Liu, Lulu Fan, Hua Wang, Guoping Sun · 2015 · Medical Oncology
  38. The thin prep rat aortic ring assay: A modified method for the characterization of angiogenesis in whole mounts
    Wenhui Zhu, Roberto Francesco Nicosia · 2002 · Angiogenesis
  39. Orthotopic Transplant Mouse Models with Green Fluorescent Protein-expressing Cancer Cells to Visualize Metastasis and Angiogenesis
    Robert M. Hoffman · 1998 · Cancer and Metastasis Reviews
  40. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
    Lisa Fusetti, Giancarlo Pruneri, A Gobbi, Cristina Rabascio, Nadia Carboni, Fedro Alessandro Peccatori, Giovanni Martinelli, Francesco Bertolini · 2000 · PubMed
  41. Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model
    E. A. te Velde, Jan M. Vogten, Martijn F.B.G. Gebbink, Joost M. van Gorp, Emile E. Voest, Inne H.M. Borel Rinkes · 2002 · British journal of surgery
  42. CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth
    Xiaodong Alan Zhuang, Federica Maione, Joseph A. Robinson, Michael Bentley, Baksho Kaul, Katharine Whitworth, Neeraj Jumbu, Elizabeth Jinks, Jonas Byström, Pietro Gabriele et al. · 2020 · JCI Insight
  43. Tumor Hepatocytes and Basement Membrane-Producing Cells Specifically Express Two Different Forms of the Endostatin Precursor, Collagen Xviii, in Human Liver Cancers
    Orlando C. Musso, Nathalie Théret, Ritva Heljäsvaara, Marko Rehn, Bruno Turlin, Jean Pierre Campion, Taina A. Pihlajaniemi, Bruno Clément · 2001 · Hepatology
  44. A 100-200 MHz ultrasound biomicroscope
    D.A. Knspik, Brian G. Starkoski, Charles J. Pavlin, F. Stuart Foster · 2000 · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control
  45. Can tumor angiogenesis be inhibited without resistance?
    Kathy D. Miller, Christopher J. Sweeney, George W. Sledge · 2005 · Birkhäuser Basel eBooks
  46. A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy
    Xu Yf, L-P Zhu, Boqiang Hu, G-F Fu, H-Y Zhang, J-J Wang, G-X Xu · 2006 · Cancer Gene Therapy
  47. The tumour microenvironment: a novel target for cancer therapy
    E Hanna, John S. Quick, S. K. Libutti · 2008 · Oral Diseases
  48. GENE THERAPY FOR PROSTATE CANCER:
    Kevin Joseph Harrington, Christine Spitzweg, Andrew Rea Bateman, J.C. MORRIS, Richard G. Vile · 2001 · The Journal of Urology
  49. Angiogenesis and Metabolism: Entwined for Therapy Resistance
    Jiménez-Valerio, Gabriela, Casanovas, Oriol · 2017 · Trends in cancer
  50. Combination antiangiogenic therapy: Increased efficacy in a murine model of Wilms tumor
    Samuel Z. Soffer, James T. Moore, Eugene S. Kim, Jianzhong Huang, Akiko Yokoi, Christina A. Manley, Kathleen O’Toole, Charles J.H. Stolar, William Middlesworth, Darrell J. Yamashiro et al. · 2001 · Journal of Pediatric Surgery
  51. Overexpression of Collagen XVIII Is Associated with Poor Outcome and Elevated Levels of Circulating Serum Endostatin in Non–Small Cell Lung Cancer
    Toshihiko Iizasa, Hao Chang, Makoto Suzuki, Mizuto Otsuji, Sana Yokoi, Masako Chiyo, Shinichiro Motohashi, Kazuhiro Yasufuku, Yasuo Sekine, Akira Iyoda et al. · 2004 · Clinical Cancer Research
  52. Immunotherapy of Malignant Diseases
    Eric C. Ko, Xinhui Wang, Soldano Ferrone · 2003 · International Archives of Allergy and Immunology
  53. Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists
    Gopalakrishna Pillai, Maria Lourdes Ceballos-Coronel · 2013 · SAGE Open Medicine
  54. Drug resistance associated with antiangiogenesis therapy
    Hans Petter Eikesdal, Raghu Kalluri · 2009 · Seminars in Cancer Biology
  55. Current Status and Study Progress of Recombinant Human Endostatin in Cancer Treatment
    Kai Li, Mingliang Shi, Shukui Qin · 2018 · Oncology and Therapy
  56. Contributory role of 5-lipoxygenase and its association with angiogenesis in the promotion of inflammation-associated colonic tumorigenesis by cigarette smoking
    Yi-Ni Ye, Edgar Shiu-Lam Liu, Vivian Yvonne Shin, William Ka Kei Wu, Chi‐Hin Cho · 2004 · Toxicology
  57. Antiangiogenic and antivascular therapy for cancer
    Giulia Taraboletti · 2001 · Current Opinion in Pharmacology
  58. Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: Involvement of the vascular endothelial growth factor receptor 2
    Diego Guidolin, Giovanna Albertin, Raffaella Spinazzi, Elisa Sorato, Alessandra Mascarin, Donatella Cavallo, Michele Antonello, Doménico Ribatti · 2008 · Peptides
  59. Direct Numerical Simulations of Micro-Bubble Expansion in Gas Embolotherapy
    Tao Ye, Joseph L. Bull · 2004 · Journal of Biomechanical Engineering
  60. Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases
    Pralhad Tayade, Madhusudan N. Saraf, Kale Rajendrakumar · 2003 · Journal of Pharmacy and Pharmacology
  61. Small Molecule Inhibitors of Tumor-Promoted Angiogenesis, Including Protein Tyrosine Kinase Inhibitors
    James M. Hamby, Hollis D. Showalter · 1999 · Pharmacology & Therapeutics
  62. Zinc ligand-disrupted recombinant human Endostatin: Potent inhibition of tumor growth, safety and pharmacokinetic profile
    B. Kim Lee Sim, William E. Fogler, Xin Hua Zhou, Hong Liang, John W. Madsen, Kieu Luu, Michael S. O’Reilly, Joseph E. Tomaszewski, Anne H. Fortier · 1999 · Angiogenesis
  63. Exercise increases endostatin in circulation of healthy volunteers
    J. Gu, G. Gadonski, Julie Wang, I. Makey, T. Adair · 2004 · BMC Physiology
  64. Antiangiogenic agents and their promising potential in combined therapy
    Patricia A Burke, Sally J. DeNardo · 2001 · Critical Reviews in Oncology/Hematology
  65. Antiangiogenic activity of 4-O-methylgallic acid from Canavalia gladiata, a dietary legume
    Ki Suk Jeon, Hee-Jun Na, Young-Myeong Kim, Ho Jeong Kwon · 2005 · Biochemical and Biophysical Research Communications
  66. Plexin D1 Expression Is Induced on Tumor Vasculature and Tumor Cells: A Novel Target for Diagnosis and Therapy?
    Ilse Roodink, Jos Raats, Bert van der Zwaag, Kiek N. Verrijp, Benno Küsters, Hans van Bokhoven, Marianne Linkels, Robert M.W. de Waal, William P. J. Leenders · 2005 · Cancer Research
  67. Nanoparticle Preconditioning for Enhanced Thermal Therapies in Cancer
    Mithun M. Shenoi, Neha B. Shah, Robert J. Griffin, Gregory M. Vercellotti, John C. Bischof · 2011 · Nanomedicine
  68. BRCA1 Plays a Role in the Hypoxic Response by Regulating HIF-1α Stability and by Modulating Vascular Endothelial Growth Factor Expression
    Hyo Jin Kang, Hee Jeong Kim, Jeong-Keun Rih, Thomas L. Mattson, Kyu Won Kim, Chi‐Heum Cho, Jennifer S. Isaacs, Insoo Bae · 2006 · Journal of Biological Chemistry
  69. Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues
    R. Murata, J. Overgaard, M. R. Horsman · 2001 · International Journal of Radiation Biology
  70. Neoplastic cells and proliferating endothelial cells express connective tissue growth factor (CTGF) in glioblastoma
    Lihua Pan, Takaaki Beppu, Akira Kurose, Kohei Yamauchi, Atsushi Sugawara, Michiyasu Suzuki, Akira Ogawa, Takashi Sawai · 2002 · Neurological Research
  71. Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy.
    Michael Streit, Antonia E. Stephen, T Hawighorst, Kant M. Matsuda, Bernhard Lange‐Asschenfeldt, Lawrence F. Brown, Joseph Phillip Vacanti, Michael J. Detmar · 2002 · PubMed
  72. Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice
    Tsukasa Kotoh, Dipok Kumar Dhar, Reiko Masunaga, Hideki Tabara, Mitsuo Tachibana, Hirofumi Kubota, Hitoshi Kohno, Naofumi Nagasue · 1999 · Surgery
  73. Asiatic Acid Inhibits Pro-Angiogenic Effects of VEGF and Human Gliomas in Endothelial Cell Culture Models
    Chandagirikoppal V. KAVITHA, Chapla Agarwal, Rajesh Agarwal, Gagan Deep · 2011 · PLoS ONE
  74. Disruption of the KEX1 gene inPichia pastoris allows expression of full-length murine and human endostatin
    Thomas Boehm, Steven Robert Pirie-Shepherd, Loc B Trinh, Joseph Shiloach, Judah Folkman · 1999 · Yeast
  75. Design, Synthesis, and Evaluation of Orally Active 4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Inhibitors
    R. M. Borzilleri, Xiaoping Zheng, Ligang Qian, Christopher D. Ellis, Zhen‐Wei Cai, Barri Swain Wautlet, Steve Mortillo, Robert Jeyaseelan, Daniel W. Kukral, Aberra Fura et al. · 2005 · Journal of Medicinal Chemistry
  76. Differential Antiproliferative Effects of Calcitriol on Tumor-Derived and Matrigel-Derived Endothelial Cells
    Ivy Chung, Michael K.K. Wong, Geraldine Flynn, Wei-Dong Yu, Candace S. Johnson, Donald L. Trump · 2006 · Cancer Research
  77. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins
    Denis Gingras, Sylvie Lamy, Richard Béliveau · 2000 · Biochemical Journal
  78. Molecular pathways in bladder cancer
    Stephen G. Williams, John P. Stein · 2004 · Urological Research
  79. Merkel Cell Carcinoma of the Skin and Mucosa
    Stephen N. Snow, Paul O. Larson, Stephen P. Hardy, Michael L. Bentz, DAVID D. MADJAR, Anya Landeck, Howard A. Oriba, DAVID C. OLANSKY · 2001 · Dermatologic Surgery
  80. NG2 precursor cells in neoplasia: Functional, histogenesis and therapeutic implications for malignant brain tumours
    Martha Chekenya, G. J. Pilkington · 2002 · Journal of Neurocytology
  81. The Angiogenesis Inhibitor Vasostatin does not Impair Wound Healing at Tumor-Inhibiting Doses
    Bernhard Lange‐Asschenfeldt, Paula Velasco, Michael Streit, T Hawighorst, Michael J. Detmar, Sandra E. Pike, Giovanna Tosato · 2001 · Journal of Investigative Dermatology
  82. Soluble recombinant endostatin purified from Escherichia coli: antiangiogenic activity and antitumor effect.
    Xiao‐Jun Huang, Michael K. Wong, Qiang Zhao, Zhen Zhu, Kai-Ziu Wang, N Huang, Caisheng Ye, Elieser Gorelik, Mo Li · 2001 · PubMed
  83. Blood Vessels are Regulators of Growth, Diagnostic Markers and Therapeutic Targets in Prostate Cancer
    Erik Lissbrant · 2001 · Scandinavian Journal of Urology and Nephrology
  84. Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin.
    Karen A. Olson, Hugh Randolph Byers, Marc E. Key, James W. Fett · 2001 · PubMed
  85. Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes
    Akira S. Mori, Shigeki Arii, M Furutani, Masaki Mizumoto, S Uchida, H Furuyama, Yoko Kondo, Manuel J. Gorrín-Rivas, Katsuyoshi Furumoto, Yasufumi Kaneda et al. · 2000 · Gene Therapy
  86. Angiogenesis in hematologic malignancies
    Thomas M. Moehler, Kai Neben, Anthony Dick Ho, Hartmut Goldschmidt · 2001 · Annals of Hematology
  87. Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium–derived factor in a xenograft model
    Lisa P. Abramson, Veronica M. Stellmach, Jennifer A. Doll, Mona L. Cornwell, ROBERT MASON ARENSMAN, Susan E. Crawford · 2003 · Journal of Pediatric Surgery
  88. A flanking attack on cancer
    Douglas Hanahan · 1998 · Nature Medicine
  89. Piceatannol, a Natural Analog of Resveratrol, Exerts Anti-angiogenic Efficiencies by Blockage of Vascular Endothelial Growth Factor Binding to Its Receptor
    Weihui Hu, Diana Kun Dai, Brody Zhong-Yu Zheng, Ran Duan, Tina Ting-Xia Dong, Qiwei Qin, Karl Wah Keung Tsim · 2020 · Molecules
  90. Radiation Combined With Antiangiogenic and Antivascular Agents
    M. OʼReilly · 2005 · Seminars in Radiation Oncology
  91. Optimal Impulsive Control With Application to Antiangiogenic Tumor Therapy
    Filippo Cacace, Valerio Cusimano, Pasquale J Palumbo · 2018 · IEEE Transactions on Control Systems Technology
  92. Targeting tumor blood vessels: an adjuvant strategy for radiation therapy
    Dietmar W. Siemann, Kenneth H. Warrington, Michael R. Horsman · 2000 · Radiotherapy and Oncology
  93. Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody
    Karen A. Olson, Hugh Randolph Byers, Marc E. Key, James W. Fett · 2002 · International Journal of Cancer
  94. Differential sensitivity of two adenocarcinoma xenografts to the anti‐vascular drugs combretastatin A4 phosphate and 5,6‐dimethylxanthenone‐4‐acetic acid, assessed using MRI and MRS
    Daniel A. Beauregard, R. Barbara Pedley, Sally A. Hill, Kevin Michael Brindle · 2002 · NMR in Biomedicine
  95. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden.
    Howard M. Katzenstein, ALFRED W. RADEMAKER, Christof Senger, Helen R. Salwen, Nadine N. Nguyen, Paul Scott Thorner, Louis Litsas, Susan Lerner Cohn · 1999 · PubMed
  96. Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis
    Jeff H. Tsai, Sosina Makonnen, Michael D. Feldman, Chandra M. Sehgal, Amit M. Maity, William M. F. Lee · 2005 · Cancer Biology & Therapy
  97. Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus
    Ryuya Yamanaka, Susan A. Zullo, Jay Ramsey, Masafumi Onodera, Ryuichi Tanaka, Michael R Blaese, Kleanthis G. Xanthopoulos · 2001 · Cancer Gene Therapy
  98. Endostatin therapy reveals a U-shaped curve for antitumor activity
    Robert M. Tjin Tham Sjin, Jennifer Naspinski, Amy E. Birsner, C Li, R Chan, K-M Lo, Stephen D. Gillies, David Zurakowski, Judah Folkman, Jude R. Samulski et al. · 2006 · Cancer Gene Therapy
  99. Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer
    Annemarie H.G. Hansma, Henk J. Broxterman, I. van der Horst, Yuana Yuana, Epie Boven, Giuseppe Giaccone, Herbert M. Pinedo, Klaas Hoekman · 2005 · Annals of Oncology
  100. Vascular morphogenesis in the ovary
    Hellmut G. Augustin · 2000 · Best Practice & Research Clinical Obstetrics & Gynaecology